Cochrane Reviews and Dermatological Trials Outcome Concordance: Why Core Outcome Sets Could Make Trial Results More Usable

Schmitt, Jochen and Lange, Toni and Kottner, Jan and Prinsen, Cecilia A. C. and Weberschock, Tobias and Hahnel, Elisabeth and Apfelbacher, Christian and Brandstetter, Susanne and Dreher, Andreas and Stevens, Giles and Burden-Teh, Esther and Rogers, Natasha and Spuls, Phyllis and Grainge, Matthew J. and Williams, Hywel C. and Jacobi, Lena (2019) Cochrane Reviews and Dermatological Trials Outcome Concordance: Why Core Outcome Sets Could Make Trial Results More Usable. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 139 (5). pp. 1045-1053. ISSN 0022-202X, 1523-1747

Full text not available from this repository. (Request a copy)

Abstract

Evidence-based health care requires that relevant outcomes for patients are included in clinical trials investigating treatment effects, allowing subsequent systematic reviews to summarize all relevant evidence to guide clinical practice. Currently, no gold standard of outcome choice for dermatology trials and reviews exists. We systematically assessed concordance between efficacy outcomes in a random sample of 10 Cochrane Skin systematic reviews and the 220 dermatology trials included. Reviews did not include 742 (68%) of the 1,086 trial outcomes. Of the 60 outcomes the reviews sought, 17 (28%) were not reported in any trial, while 12 were assessed in <50% of trials. For 11 of 23 (48%) primary review outcomes, meta-analysis was impossible, because trial outcomes were absent or unclear. This small overlap of review/trial outcomes could suggest that trials are not measuring the outcomes perceived to be the most important by patients, clinicians, systematic reviewers, and trialists. The lack of standardized outcome measures, poor reporting of outcomes in trials, and low concordance of outcomes between reviews and primary studies could be improved by the development and implementation of Core Outcome Sets. These are an agreed-upon minimum set of key outcomes, for specified conditions, to be reported in all trials.

Item Type: Article
Uncontrolled Keywords: RANDOMIZED CONTROLLED-TRIALS; CLINICAL-TRIALS; IMPACT; BIAS;
Subjects: 600 Technology > 610 Medical sciences Medicine
Divisions: Medicine > Institut für Epidemiologie und Präventivmedizin
Depositing User: Dr. Gernot Deinzer
Date Deposited: 09 Apr 2020 09:54
Last Modified: 09 Apr 2020 09:54
URI: https://pred.uni-regensburg.de/id/eprint/27113

Actions (login required)

View Item View Item